| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.0096 | 0.8 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |